AzTrials
AzTrials

CataractNCT04875247

IOLMASTER 700 Central Topography Workflow Study.

An observational study of Cataract, run by OFTALVIST (Oftalmología Vistahermosa S.L) at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The use of ocular biometers like IOLMaster 700, is a common practice to identify several ocular parameters such as the keratometry of the cornea and the axial length of the eye, which are necessary for calculating the power of the intraocular lens in cataract surgery. Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Cataract
What is being tested?
IOLMaster 700 with central topography, IOLMaster 700 without central topography plus Cassini and IOLMaster 700 without central topography plus Pentacam
Type of treatment
Medical device
How many people
100 participants
Where
1 siteSpain
Study dates
12 May 2021to 9 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients older than 50 years with cataracts that have to undergo a cataracts surgery.

Who may be able to join

  • Patients that have to undergo a cataract surgery
  • Patients older than 50 years.

Who cannot join

  • Patients that have already undergone a previous corneal surgery.
  • Patients suffering from keratoconus.
  • Patients exhibiting corneal scars
  • Patients exhibiting pterygium

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • OFTALVIST (Oftalmología Vistahermosa S.L.)

    Jeréz de La Frontera, Cádiz, 11407

Other trials in Spain

About this study

The use of ocular biometers like IOLMaster 700, is a common practice to identify several ocular parameters such as the keratometry of the cornea and the axial length of the eye, which are necessary for calculating the power of the intraocular lens in cataract surgery. However, the additional use of other devices, such as Cassini and Pentacam is used to obtain more information of the central topography of the eye. Recently, a new version of the IOLMaster 700 equipment that provides much more detailed information than in its previous version has been presented. The objective of this study is to measure the time that the new IOLMaster 700 takes to perform these measurements of the central topography and compare it with the time it takes using the central topography using the standard IOLMaster 700 version with Cassini on one hand and Pentacam on the other.

It is hypothesized that the use of the new version of the IOLMaster 700 equipment alone can reduce the time of measurements and improve the clinic workflow.

Conditions
Cataract
Being tested
IOLMaster 700 with central topography, IOLMaster 700 without central topography plus Cassini, IOLMaster 700 without central topography plus Pentacam
Medical subject headings
Cataract

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IOLMaster 700 with central topographyDevice

    The time needed to perform the measurement using the IOLMaster700 equipment with central topography will be recorded.

  • IOLMaster 700 without central topography plus CassiniDevice

    The time needed to perform the measurement using the IOLMaster700 equipment without central topography plus the Cassini equipment will be recorded.

  • IOLMaster 700 without central topography plus PentacamDevice

    The time needed to perform the measurement using the IOLMaster700 equipment without central topography plus the Pentacam equipment will be recorded.

Study groups in NCT04875247
Study groupRoleWhat they receive
Single armAll patients will be assigned to this cohort.
Receives: Device: IOLMaster 700 with central topography; Device: IOLMaster 700 without central topography plus Cassini; Device: IOLMaster 700 without central topography plus Pentacam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time needed to do the measurements with each equipment

    Time needed to do the measurements with each equipment

    Measured: 1 day (Cataract pre-surgery visit)

Secondary outcomes (1)
  1. Central topography

    Measurement of keratometry (K): Flat Keratometry (K1) and Steep Keratometry (K2)

    Measured: 1 day (Cataract pre-surgery visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2021
  2. Study start12 May 2021
  3. Primary completion9 Sep 2021
  4. Study completion9 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04875247
Sponsor's protocol ID
IOLWORK
Status last verified
Feb 2023
First submitted
3 May 2021
Last updated
17 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ruiz-Mesa R, Ruiz-Santos M, Blanch-Ruiz J, Jimenez-Nieto A. Acquisition Time for Swept-Source Optical Biometry Plus Corneal Power Measurement During Cataract Evaluation. Clin Ophthalmol. 2022 Mar 5;16:661-668. doi: 10.2147/OPTH.S351845. eCollection 2022.

    PubMed 35282169

Questions about this trial

What is this clinical trial studying?

An observational study of Cataract, run by OFTALVIST (Oftalmología Vistahermosa S.L) at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time needed to do the measurements with each equipment (time frame: 1 day (Cataract pre-surgery visit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04875247, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in